Latest Capital Raising News

I Synergy Group Limited has announced a renounceable entitlement offer aiming to raise approximately $1 million to fund new projects and operational growth. The offer is fully underwritten and open to shareholders across multiple Asia-Pacific markets.

Asra Minerals Limited has launched a substantial options offer linked to a recent $3 million placement, aiming to enhance liquidity and satisfy obligations under the placement. The company plans to list these options on the ASX by the end of June 2025.

Magnum Mining and Exploration Limited has announced a pro-rata entitlement offer to raise up to $2.24 million, aiming to fund key exploration projects across Brazil, the US, and Nevada. The offer carries significant dilution risks for non-participating shareholders and underscores ongoing operational uncertainties.

Magnum Mining and Exploration has initiated a $2.2 million entitlement offer at a significant discount, aiming to strengthen its capital base and fund key projects in Australia and the US.

Robex Resources Inc., a Canadian gold explorer and producer with key assets in West Africa, has launched a fully underwritten initial public offering (IPO) on the ASX to raise A$120 million. The capital will primarily support the development of its advanced Kiniero Gold Project in Guinea, alongside ongoing operations at the Nampala Mine in Mali.

Matrix Composites & Engineering has declined a reverse merger proposal from Advanced Innergy Solutions, citing undervaluation and strong standalone prospects. The decision underscores Matrix's confidence in its growth strategy and capital position.

HITIQ Limited has pushed back the closing date for its entitlement issue offer to June 20, adjusting the timeline for its capital raising efforts.

High-Tech Metals Limited has successfully completed a modest capital raise through a non-renounceable entitlement offer, issuing shares at $0.15 each alongside free attaching options. The company now holds discretion over a significant shortfall placement, which could influence its capital structure in the coming months.

Codeifai Limited has locked in $570,000 through a discounted share placement, aiming to fuel its digital platform growth and strategic initiatives.

Recce Pharmaceuticals has completed a A$15.8 million capital raise to fund pivotal Phase 3 clinical trials and progress its FDA application, positioning the company for potential commercial breakthroughs in antibiotic-resistant infections.

Scorpion Minerals has completed detailed pre-drilling exploration at its Pharos Gold Project in Western Australia and is poised to begin RC drilling targeting multiple high-grade gold zones along a prolific shear corridor.

AdAlta Limited has successfully raised $1.1 million through a renounceable rights issue, positioning itself to advance key CAR-T licensing and immunotherapy projects. The capital injection underscores confidence from leadership and investors amid a transformative phase for the biotech company.